Description

3,4-Dihydro-2H-Pyrido[3,2-B]-[1,4]Oxazine-2-Carboxylic Acid is a high-purity heterocyclic carboxylic acid building block of significant interest in advanced organic synthesis. This compound matters for its role as a critical intermediate in the development of novel pharmaceutical agents and bioactive molecules. It is primarily needed by research institutions, pharmaceutical R&D departments, and fine chemical manufacturers focused on creating new drug candidates, particularly in therapeutic areas requiring complex nitrogen-oxygen heterocycles.

Application

• Pharmaceutical Intermediate: A key synthon for the synthesis of potential active pharmaceutical ingredients (APIs) targeting central nervous system (CNS) disorders, oncology, and infectious diseases.
• Medicinal Chemistry Research: Used in high-throughput screening and structure-activity relationship (SAR) studies to develop novel pharmacophores.
• Organic Synthesis Building Block: Employed in constructing complex polyheterocyclic frameworks due to its fused pyrido-oxazine structure.
• Agrochemical Development: Serves as a precursor in the research and synthesis of new-generation herbicides and fungicides.
• Chemical Biology Probes: Utilized in the design and synthesis of molecular probes for studying enzyme mechanisms and biological pathways.
• Material Science Research: Investigated as a monomer or precursor for specialty polymers and functional organic materials.

Basic Information

Product Name	3,4-Dihydro-2H-Pyrido[3,2-B]-[1,4]Oxazine-2-Carboxylic Acid
CAS No.	1086375-44-1
Molecular Formula	C8H8N2O3
Molecular Weight	180.16 g/mol
Synonyms	2H-Pyrido[3,2-b][1,4]oxazine-2-carboxylic acid, 3,4-dihydro-; 3,4-Dihydro-2H-pyrido[3,2-b][1,4]oxazine-2-carboxylic acid; 1086375-44-1; Pyrido[3,2-b][1,4]oxazine-2-carboxylic acid, 3,4-dihydro-2H-; DHPO-2-COOH; 2-Carboxy-3,4-dihydro-2H-pyrido[3,2-b][1,4]oxazine
EINECS	Contact for details

Quality Control

Our 3,4-Dihydro-2H-Pyrido[3,2-B]-[1,4]Oxazine-2-Carboxylic Acid is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC for purity and identity confirmation via spectroscopic methods (NMR, IR, MS), to ensure it meets the stringent requirements for pharmaceutical R&D. Certificates of Analysis (COA) with detailed chromatographic and spectral data are provided to guarantee traceability, consistency, and compliance with your research protocols.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at a controlled room temperature (15-25°C). This compound is moisture-sensitive (hygroscopic); keep the container tightly sealed under an inert atmosphere if specified. Keep away from strong oxidizing agents.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to structure
Identification (NMR)	Conforms to structure
Purity (HPLC)	≥ 98.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 10 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.